But, once cancer cells become defective in TGF-β tumor-suppressive responses, they utilize TGF-β to their benefit to induce immune evasion, growth factor synthesis, conferring to an invasive phenotype with ability to metastasize [180]. This evidence concerns the gene TGFB1 and cancer.